전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-1 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,373 programs
CGTLimited DatastaleBlueWhale Bio (Cohort D only)Phase 1

huCART19-IL18 (huCART19-IL18)

Chronic Lymphocytic Leukemia; Non-hodgkin Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleFollicular Lymphoma FoundationPhase 1

huCART19-IL18-eDHFR cells (huCART19-IL18-eDHFR cells)

Relapsed or Refractory Follicular Lymphoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleMinerva Biotechnologies Corpora…Phase 1

huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells (huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleMinerva Biotechnologies Corpora…Phase 1

huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells @ RP2D (huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells @ RP2D)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleZhujiang HospitalPhase 1

humanized CD19 CAR-T Cells with TLR2 (humanized CD19 CAR-T Cells with TLR2)

B Lymphoblastic Leukemia/Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBaylor College of MedicinePhase 1

i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells (i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells)

Relapsed Neuroblastoma; Refractory Neuroblastoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

iC9-CAR.B7-H3 T Cell Therapy (iC9-CAR.B7-H3 T Cell Therapy)

Breast Cancer; Relapse · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

iC9-CAR.B7-H3 T cell infusion (iC9-CAR.B7-H3 T cell infusion)

Pancreas Cancer; Relapse · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

iC9-CAR.B7-H3 T cells (iC9-CAR.B7-H3 T cells)

Ovary Neoplasm; Ovarian Cancer · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleThe V FoundationPhase 1

iC9-CAR19 T cells (iC9-CAR19 T cells)

Lymphoma; Lymphoma, B-Cell · Lymphoma

#Lymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleBellicum PharmaceuticalsPhase 1

iC9.GD2.CAR.IL-15 T Infusion (iC9.GD2.CAR.IL-15 T Infusion)

Lung Cancer; Small Cell Lung Carcinoma · GD2

#GD2#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

iC9.GD2.CAR.IL-15 T-cells (iC9.GD2.CAR.IL-15 T-cells)

Neuroblastoma; Osteosarcoma · GD2

#GD2#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleMarino Biotechnology Co., Ltd.Phase 1

iPD1 CD19 eCAR T cells (iPD1 CD19 eCAR T cells)

Relapsed or Refractory B-cell Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleZhejiang UniversityPhase 1

iPSC-NK cells (iPSC-NK cells)

AML, Adult · AML, Adult

#AMLAdult#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleGruppo Italiano Malattie EMatol…Preclinical

idelalisib and rituximab (idelalisib and rituximab)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Preclinical#monoclonal-antibody#Gruppo
Trials 1Status Active
AntibodyLimited DatastaleUniversity Hospital, BordeauxPhase 3

immunomodulatory treatment by rituximab (immunomodulatory treatment by rituximab)

Mental Disorder · Mental Disorder

#MentalDisorder#Antibody#Phase3#monoclonal-antibody#University
Trials 1Status Recruiting
AntibodyLimited DatastaleSpectrum Pharmaceuticals, IncPhase 2

indium-111-ibritumomab tiuxetan (indium-111-ibritumomab tiuxetan)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#monoclonal-antibody#Spectrum
Trials 1Status Discontinued
AntibodyLimited DatastaleRochePhase 3

injection Combined Bevacizumab and Fasudil (injection Combined Bevacizumab and Fasudil)

Retinal Vein Occlusion · Retinal Vein Occlusion

#RetinalVeinOcclusion#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleJinnah Postgraduate Medical Cen…Preclinical

injection Sekucinumab (injection Sekucinumab)

Erythrodermic Psoriasis · Erythrodermic Psoriasis

#ErythrodermicPsoriasis#Antibody#Preclinical#monoclonal-antibody#Jinnah
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

injection bevacizumab (injection bevacizumab)

Retinal Vein Occlusion · Retinal Vein Occlusion

#RetinalVeinOcclusion#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active

114 / 119 pages

← PreviousNext →